Telemedicine Flourishes Despite Hurdles

In Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC, the Federal Circuit jumped on the bandwagon of scrutinizing the types of patents that can be listed in the Food & Drug Administration (FDA) Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations), and decided that the “device” patents at issue were not properly listable.

The start of a new year often inspires lofty resolutions, if not illusions of grandeur, about the habits we’ll develop and professional goals we’ll conquer: more billable hours, bigger matters, rapid career advancement, and the like.

On December 17, 2024, the U.S. Federal Trade Commission announced its final “Junk Fees Rule” to prevent certain practices related to pricing in the live-event ticketing and short-term lodging industries.